N Iwamoto Selected Research

N Iwamoto Research Topics

Disease

7	Rheumatoid Arthritis 01/2022 - 11/2009
5	Type 2 Diabetes Mellitus (MODY) 03/2016 - 09/2001
4	Insulin Resistance 12/2001 - 03/2001
2	Dermatomyositis (Dermatopolymyositis) 01/2021 - 01/2009
2	Necrosis 01/2020 - 11/2009
2	Lupus Nephritis 04/2019 - 07/2018
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2018
1	Familial Mediterranean Fever (Periodic Disease) 01/2018
1	Nausea 10/2015
1	Nasopharyngitis 10/2015
1	Constipation 10/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2011
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 09/2010
1	T-Cell Leukemia (Leukemia, T Cell) 09/2010
1	Xerostomia 09/2010
1	Infections 09/2010
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2010
1	Spinal Cord Diseases 09/2010
1	Sialadenitis 09/2010
1	Palindromic rheumatism 08/2010
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2005
1	Hydrothorax 09/2004
1	Pleural Effusion (Pleural Effusions) 09/2004
1	Erectile Dysfunction 08/2002
1	Diabetes Complications 08/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2002
1	Renal Insufficiency (Renal Failure) 06/2002
1	Fatty Liver 12/2001
1	Non-alcoholic Fatty Liver Disease 12/2001
1	Hypertriglyceridemia 12/2001
1	Hyperlipidemias (Hyperlipidemia) 12/2001
1	Platelet Glycoprotein IV Deficiency 12/2001
1	Obesity 12/2001
1	Hyperinsulinism (Hyperinsulinemia) 03/2001
1	Neoplasms (Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 01/2021 - 01/2009
3	Hypoglycemic Agents (Hypoglycemics)IBA 10/2001 - 03/2001
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2021
2	AntigensIBA 01/2021 - 01/2000
2	Abatacept (Orencia)FDA Link 01/2021 - 01/2020
2	Anti-Citrullinated Protein AntibodiesIBA 01/2020 - 08/2010
2	dulaglutideIBA 03/2016 - 10/2015
2	Glucagon-Like Peptide-1 ReceptorIBA 03/2016 - 10/2015
2	Liraglutide FDA Link 03/2016 - 10/2015
2	CholesterolIBA 01/2011 - 12/2001
2	EpitopesIBA 08/2010 - 01/2000
2	Triglycerides (Triacylglycerol)IBA 12/2001 - 12/2001
2	Insulin (Novolin)FDA Link 12/2001 - 03/2001
2	HDL CholesterolIBA 12/2001 - 12/2001
2	LipidsIBA 12/2001 - 09/2001
1	Janus KinasesIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2020
1	Prednisolone (Predate)FDA LinkGeneric 07/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2018
1	CytokinesIBA 01/2018
1	BilirubinIBA 01/2011
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2010
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 11/2009
1	LigandsIBA 11/2009
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 11/2009
1	Transfer RNA (tRNA)IBA 01/2009
1	AutoantibodiesIBA 01/2009
1	Ligases (Synthetase)IBA 01/2009
1	Peptides (Polypeptides)IBA 01/2009
1	Gemcitabine FDA Link 10/2005
1	TegafurIBA 10/2005
1	UracilIBA 10/2005
1	Aldehyde Reductase (Aldose Reductase)IBA 08/2002
1	Glucose (Dextrose)FDA LinkGeneric 12/2001
1	Nonesterified Fatty Acids (NEFA)IBA 12/2001
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2001
1	Codon (Codons)IBA 12/2001
1	Glucose Transporter Type 4IBA 10/2001
1	mangiferinIBA 09/2001
1	Blood Glucose (Blood Sugar)IBA 03/2001
1	Vicia lectinsIBA 01/2000
1	LectinsIBA 01/2000
1	Methionine (L-Methionine)FDA Link 01/2000
1	Glycoproteins (Glycoprotein)IBA 01/2000

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 08/2002 - 06/2002
1	Aftercare (After-Treatment) 01/2021
1	Therapeutics 04/2019
1	Liver Transplantation 09/2010
1	Combination Drug Therapy (Combination Chemotherapy) 10/2005
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 09/2004
1	Pleurodesis 09/2004